[{"NetIncomeLoss_1_Q1_USD":-19915000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5865000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":11667967.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.011,"Depreciation_1_Q1_USD":10000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":19632000.0,"AssetsCurrent_0_Q1_USD":109668000.0,"OtherNoncashIncomeExpense_1_Q1_USD":11000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":15721268.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":288000.0,"IncomeTaxesPaidNet_1_Q1_USD":13000.0,"CommonStockSharesIssued_0_Q1_shares":12349961.0,"Assets_0_Q1_USD":110563000.0,"ShareBasedCompensation_1_Q1_USD":2931000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":281000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":17259796.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":106126000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":19632000.0,"OperatingLeaseLiability_0_Q1_USD":336000.0,"Cash_0_Q1_USD":1532000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":13953000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":354000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-16000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-29000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":68000.0,"CommonStockValue_0_Q1_USD":12000.0,"OtherReceivablesNetCurrent_0_Q1_USD":214000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":47000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":20580000.0,"OtherAssetsCurrent_0_Q1_USD":676000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":6364000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":1917000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":317000.0,"OtherAssetsNoncurrent_0_Q1_USD":572000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":107658000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":122000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":968047000.0,"Liabilities_0_Q1_USD":9008000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":171000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-406000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2931000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16961000.0,"ProceedsFromWarrantExercises_1_Q1_USD":660000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":183000.0,"LiabilitiesCurrent_0_Q1_USD":8886000.0,"AccountsPayableCurrent_0_Q1_USD":2522000.0,"NonoperatingIncomeExpense_1_Q1_USD":-29000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":107958000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2010000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.84,"ProceedsFromStockOptionsExercised_1_Q1_USD":288000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":111000.0,"ShortTermLeaseCost_1_Q1_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.005,"OperatingLeasePayments_1_Q1_USD":57000.0,"PrepaidInsurance_0_Q1_USD":572000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":42000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-19847000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":18000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":319000.0,"CommonStockSharesOutstanding_0_Q1_shares":12349961.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"OperatingIncomeLoss_1_Q1_USD":-19818000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingLeaseCost_1_Q1_USD":43000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":110563000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2931000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":361000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":214000.0,"OperatingExpenses_1_Q1_USD":19818000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-736000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.71,"ProfitLoss_1_Q1_USD":-19915000.0,"StockholdersEquity_0_Q1_USD":101555000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":300000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-866504000.0,"LeaseCost_1_Q1_USD":50000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":3603000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q1_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1485000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]